Business Context and Reporting Period
Company: Innovative Eyewear, Inc. (Ticker: LUCY)
Filing Type: Form 8-K (Current Report)
Report Date: June 20, 2025 (Event Date); June 24, 2025 (Closing Date)
Context: The Company, an emerging growth company incorporated in Florida, entered into inducement letter agreements to facilitate the exercise of existing warrants and the issuance of new warrants. The transaction closed on June 24, 2025.
Key Financial Metrics
- Gross Proceeds: Approximately $2.2 million (prior to deducting placement agent fees and offering expenses).
- Use of Proceeds: Working capital and general corporate purposes.
- Placement Agent Fees:
- Cash Fee: 7.5% of gross proceeds.
- Management Fee: 1.0% of gross proceeds.
- Accountable Expenses: $50,000.
- Non-accountable Expenses: $25,000.
- Clearing Expenses: $15,950.
- Equity Issuance Details:
- Existing Warrants Exercised: 746,782 shares at $2.60 per share.
- New Warrants Issued (Series I): 2,240,346 warrants at $0.125 per warrant (Exercise Price: $2.60).
- Placement Agent Warrants (PA Warrants): 56,009 warrants (Exercise Price: $3.25).
- Ordinary Course PA Warrants: 73,990 warrants (Exercise Price: $3.25).
Note: The filing does not provide specific values for revenue, net profit, operating cash flow, margins, total debt, or liquidity ratios.
Material Changes
This filing reports a specific capital raise event rather than a periodic financial performance update. The material change is the increase in outstanding equity instruments and cash inflow resulting from the warrant exercise and new issuance. The Company agreed to a 30-day lock-up period on issuing new common stock or equivalents and a one-year restriction on Variable Rate Transactions following the closing.
Guidance, Outlook, and Risks
- Management Commentary: The Company intends to use net proceeds for working capital and general corporate purposes.
- Registration Obligations: The Company must file a resale registration statement for the New Warrants within 30 days and use commercially reasonable efforts to have it declared effective within 60 days (or 90 days in case of a full review).
- Risks and Contingencies:
- The New Warrants and Placement Agent Warrants were issued unregistered, relying on Section 4(a)(2) and Rule 506 exemptions.
- These securities cannot be offered or sold in the U.S. absent registration or an exemption.
- Future dilution is possible upon the exercise of the 2,240,346 New Warrants and 129,999 Placement Agent Warrants.
Investor Verification Checklist
- Verify the effective date of the Resale Registration Statement for the New Warrants to confirm liquidity for holders.
- Confirm the exact net proceeds after deducting the 8.5% cash fees and fixed expenses ($90,950 total fixed costs).
- Review the full text of the Inducement Letter Agreements (Exhibit 10.1) for specific exceptions to the lock-up and Variable Rate Transaction restrictions.
- Monitor the Company's cash burn rate to assess if the $2.2 million gross proceeds are sufficient for the stated working capital needs.
- Check for any subsequent filings regarding the "full review" status of the registration statement, which could extend the effectiveness timeline to 90 days.